Who’s Hired? Sandoz Names New Japanese Head
As Stada Brings In A Former Sandoz Executive In Portugal
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.
You may also be interested in...
Julphar has suffered an alarming turn in fortune in the last two years, on the back of export bans that have severed access to some of the company’s key markets in the Middle East. With a new CEO in place, the company is looking to transform its fortunes this year, aided by a capital restructuring that just been greenlit by shareholders.
As its CEO Jerome Carle steps down following a 67% slump in sales to date this year, UAE-based Julphar is hopeful of putting manufacturing problems behind it under a new management team.
Sandoz is to pay up to €400m for Aspen’s anesthetics and other specialty off-patent brands in Japan, strengthening the Novartis division’s local position in the hospitals market.